About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, ...
Popular weight-loss therapies like Novo Nordisk's Wegovy and Eli Lilly's Zepbound result in both fat and muscle loss.
About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, ...
About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, ...
Regeneron (NASDAQ: REGN) is testing its drug, trevogrumab, along with Wegovy and another treatment, garetosmab, in a ...
Doctors say drugs that improve muscle mass could benefit older or infirm people at greater risk of falls and fractures ...
In trials of Wegovy, up to 40% of weight loss was from a decrease in lean or fat-free mass, rather than excess fat. These experimental medicines are still a few years from possible approval. Veru ...
Wegovy and Zepbound target the GLP-1 protein to help control appetite. Veru was first with results in January from a 168-person trial, showing its enobosarm helped older patients lose 71% less ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results